NASDAQ$CRVL

CorVel Corporation · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Corvel's Q4 2020 earnings decreased compared to the same quarter last year, with revenues at $147 million and EPS at $0.64.

CorVel Corporation reported a decrease in revenues for the quarter ended March 31, 2020, with revenues of $147 million compared to $151 million in the same quarter of the prior year. Earnings per share were $0.64, slightly up from $0.63 in the prior year's quarter. The company had to make adjustments due to the COVID-19 pandemic, including a reduction in force.

  • Revenues for the quarter ended March 31, 2020 were $147 million, down from $151 million in the same quarter of the previous year.
  • Earnings per share for the quarter ended March 31, 2020, were $0.64, compared to $0.63 in the same quarter of the prior year.
  • The company implemented an 8% reduction in force in response to the COVID-19 pandemic.
  • CorVel is focusing on expanding virtual services, including telehealth, to address the challenges posed by COVID-19.

Headline financials

Total Revenue

$147M

Previous: $151M-2.7%
EPS (adj)

$0.21

Previous: $0.21+0.0%
Capital Expenditures

$4.61M

Previous: $4.97M-7.1%
Free Cash Flow

$9.92M

Previous: $5.77M+71.8%
Net Income

$11.7M

Previous: $11.8M-0.8%
Operating Income

$14.8M

No prior period
Gross Profit

$30.7M

Previous: $32.6M-5.9%
Cash & Equivalents

$83.2M

Previous: $91.7M-9.3%
Total Assets

$416M

Previous: $318M+30.9%
Stock-Based Comp

$919K

Previous: $1.24M-25.8%

Revenue & EPS history

CorVel · Revenue · Quarterly

$147M

Q4 2020-2.7%vs Q4 2019

Revenue by segment

CorVel · $249M total across 2 segments · Q4 2026

  • Patient management services
    $153M
  • Network solutions services
    $95.5M

Forward guidance

CorVel is focusing on leveraging technology and telehealth into expanded virtual services to minimize the spread of COVID-19 and quickly identify and safely treat workers’ compensation cases.

Tailwinds

  • Virtual Care platform is fully integrated with 24/7 nurse triage services.
  • Integration reduces delays in care and avoids duplicative efforts.
  • Efficient coordination of treatment for injured workers.
  • Automated integration of medical notes, reports, and documents in real time.
  • Industry leading connectivity from injury to return to work.

Headwinds

  • The company was forced to make difficult but necessary decisions at the onset of the pandemic.
  • An 8% reduction in force that began in the March quarter and continued through the June quarter in order to protect the company while maintaining operations and supporting our customers
  • Impact of the COVID-19 pandemic on our business, results of operations and financial condition is greater than our initial assessment
  • Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2019 and the Company’s Quarterly Report on Form 10-Q for the quarters ended June 30, 2019, September 30, 2019, and December 31, 2019.
  • Amount and timing of any stock repurchases under the Company’s stock repurchase program, if any, and the Company’s ability to repurchase shares of its common stock and how those repurchased shares may be used.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-1.0%

Avg return

Earnings day

-0.3%

Avg return

5 days after

+0.4%

Avg return

30 days after

48%

30 / 63 earnings

Positive

+11.8%

Q1 2014

Best reaction

-26.1%

Q3 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-0.7%+6.2%-0.9%
Q3 2026-26.1%-30.2%-21.4%
Q2 2026+4.1%+3.9%-3.8%
Q1 2026+1.2%-0.4%-0.6%
Q4 2025+2.3%+0.2%-9.1%
Q1 2025-0.3%-2.1%+4.0%
Q4 2024-0.3%+0.0%-11.5%
Q3 2025+1.7%+3.1%+5.4%
Q2 2025+3.0%+5.5%+10.4%
Q1 2024+5.9%+4.4%+5.8%
Q4 2023-2.0%-3.7%+0.2%
Q3 2023+6.1%+7.1%+5.3%
Q2 2023-4.8%-4.3%-6.3%
Q1 2023+1.6%-4.9%-6.8%
Q4 2022+1.6%-0.3%-1.1%
Q3 2022-9.9%-14.8%-5.7%
Q2 2022+0.4%+2.9%+5.7%
Q1 2022+8.1%+13.9%+18.7%
Q4 2021+4.0%+4.1%+9.7%
Q3 2021+1.4%+3.6%+2.1%
Q2 2021-7.0%-7.4%-0.2%
Q1 2021-2.9%+3.2%+7.8%
Q4 2020+8.9%+9.4%+14.4%
Q3 2020-3.2%-7.4%-23.9%
Q2 2020-0.7%-0.1%+4.1%
Q1 2020-8.4%-8.8%-7.4%
Q4 2019+4.6%+7.9%+23.0%
Q3 2019-0.5%+0.3%+1.2%
Q2 2019+5.6%+8.9%+25.6%
Q1 2019+1.0%+3.4%+8.5%
Q4 2018-3.2%-5.1%-1.1%
Q3 2018-3.8%-4.3%-11.2%
Q2 2018-3.8%-1.9%-5.6%
Q1 2018+1.8%+4.6%+9.1%
Q4 2017+4.0%+0.8%+1.8%
Q3 2017+2.7%+4.1%+8.4%
Q2 2017-8.0%-8.0%-8.2%
Q1 2017-7.7%-7.5%-19.3%
Q4 2016+8.2%+2.7%-9.7%
Q3 2016-2.3%
Q2 2016+1.4%
Q1 2016+3.8%
Q4 2015-10.6%
Q3 2015+4.2%
Q2 2015-0.1%
Q1 2015-1.2%
Q4 2014+0.0%
Q3 2014+2.4%
Q2 2014-1.7%
Q1 2014+11.8%
Q4 2012+1.3%
Q4 2013+4.5%
Q3 2013+1.6%
Q2 2013-3.8%
Q1 2013+1.7%
Q4 2010-0.7%
Q3 2012-3.4%
Q3 2011-3.4%
Q2 2012-1.7%
Q2 2011-12.3%
Q1 2012-12.3%
Q1 2011-12.3%
Q4 2011-12.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro